BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan · Delayed Price · Currency is TWD 33.80
+0.45 (1.35%)
Jul 24, 2025, 2:31 PM CST
BioLASCO Taiwan Market Cap
BioLASCO Taiwan has a market cap or net worth of 865.69 million as of July 25, 2025. Its market cap has decreased by -2.45% in one year.
Market Cap
865.69M
Enterprise Value
821.51M
Revenue
304.65M
Ranking
n/a
PE Ratio
19.31
Stock Price
33.80
Market Cap Chart
Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 865.69M, a decrease of -45.24%. That is a compound annual growth rate of -7.66%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 208.61B |
| PharmaEssentia | 171.96B |
| Bora Pharmaceuticals Co., LTD. | 85.44B |
| Lotus Pharmaceutical | 58.89B |
| Oneness Biotech | 31.47B |
| Polaris Group | 29.74B |
| Center Laboratories | 26.99B |
| Pegavision | 25.08B |